It has been 9 months since a federal court judgment was ordered for Laidlaw & Company Ltd. to cease distribution of false proxy information to investors and clients. The investment firm has complied with the order, and still in January earlier this year Relmada Therapeutics Inc. files an amendment to the previously filed lawsuit. It really is starting to look as if Relmada Therapeutics Inc.is looking for a hand out. Relmada Therapeutics Inc. has won the cease and desist order, now time show tell the story and smear a financial institution right out of business. As time has shown Laidlaw is still in business as a leading investment institution. Laidlaw & Company Ltd. is based in the United Kingdom and has many years of experience in the financial industry under its cap. The firm is also known for being a firm that raises capital from mid-level net worth investors. Funding purposes usually involve a high net worth of institutional backing, and Laidlaw & Company Ltd. has provided the backing for many investment opportunities. The financial institution is run by Mr. Mathew Eitner, the CEO, and the Chief Managing Partner Mr. James Ahern. These two individuals are continuing to make good with their business practices and create opportunities for businesses to expand through their funding practices.